presentation of rare cancers in all policies call to action
TRANSCRIPT
![Page 2: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/2.jpg)
a “Call to Action”…
![Page 3: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/3.jpg)
www.rarecancerseurope.org
![Page 4: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/4.jpg)
![Page 5: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/5.jpg)
▪ Pediatric cancers
▪ Haematologic rare neoplasms
▪ Sarcomas▪ Rare thoracic cancers▪ Neuroendocrine tumours▪ Head & neck cancers▪ Central nervous system tumours ▪ Rare female genital cancers▪ Rare urological and male genital tumours▪ Endocrine gland tumours▪ Digestive rare cancers▪ Rare skin cancers & non-cutaneous melanoma
Eur J Cancer 2011;47:2493
![Page 6: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/6.jpg)
ESMO Open. 2020;5(2):e000666
![Page 7: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/7.jpg)
www.rarecancerseurope.org
![Page 8: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/8.jpg)
![Page 9: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/9.jpg)
![Page 10: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/10.jpg)
▪ Conquering Cancer: Mission Possible
▪ Pharmaceutical Strategy for Europe
▪ Europe’s Beating Cancer Plan
▪ EU Research and Innovation Programme (2021-27) and Horizon Europe
▪ EU4Health and the European Semester Programmes
▪ Patients’ Rights in Cross-Border Healthcare
▪ A European Strategy for Data
▪ European Health Data Space
▪ Clinical Trials Regulation
▪ Proposal for a Regulation on Health Technology Assessment
▪ Orphan Medicinal Products and the Paediatric Regulations
▪ General Data Protection Regulation
Rare Cancers in All Policies
![Page 11: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/11.jpg)
![Page 12: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/12.jpg)
![Page 13: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/13.jpg)
![Page 14: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/14.jpg)
![Page 15: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/15.jpg)
![Page 16: Presentation of Rare Cancers in All Policies Call to Action](https://reader035.vdocument.in/reader035/viewer/2022062321/62a97e855731c415fb2fa70d/html5/thumbnails/16.jpg)